| Abstract | A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis. |
| Authors | P R Lyons, P K Newman, M Saunders
(Affiliation: Department of Neurology, Middlesbrough General Hospital, Cleveland, UK.)
|
| Journal | Journal of neurology, neurosurgery, and psychiatry
(J Neurol Neurosurg Psychiatry)
Vol. 51
Issue 2
Pg. 285-7
(Feb 1988)
ISSN: 0022-3050 ENGLAND |
| PMID | 3346696
(Publication Type: Journal Article)
|
| Chemical References |
- Prednisolone
- Methylprednisolone
|
| Topics |
- Administration, Oral
- Adolescent
- Adult
- Dose-Response Relationship, Drug
- Humans
- Infusions, Intravenous
- Methylprednisolone
(administration & dosage, adverse effects)
- Middle Aged
- Multiple Sclerosis
(drug therapy)
- Prednisolone
(administration & dosage)
|
